Edition:
United Kingdom

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

6,274JPY
14 Dec 2017
Change (% chg)

¥64 (+1.03%)
Prev Close
¥6,210
Open
¥6,240
Day's High
¥6,294
Day's Low
¥6,234
Volume
2,155,400
Avg. Vol
1,987,972
52-wk High
¥6,464
52-wk Low
¥4,664

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Masahiro Sakane

76 2017 Independent Chairman of the Executive Board

Christophe Weber

50 2015 President, Chief Executive Officer, Representative Director

Andrew Plump

52 2015 Chief Medical & Scientific Officer, Director

Masato Iwasaki

58 2015 President of Japan Pharma Business Unit, Director

Yasuhiko Yamanaka

61 2016 Director